Two cases of complete response after imatinib mesylate treatment of advanced GIST

被引：0
|
作者：
Papaxoinis, George [1 ]
Nikolaou, Maria [1 ]
Lianos, Evangelos [1 ]
Gaglia, Asimina [1 ]
Economopoulos, Theofanis [1 ]
Pectasides, Dimitrios [1 ]
机构：
[1] Univ Athens, Dept Internal Med Propaedeut 2, Attikon Hosp, Haidari 12462, Greece
来源：
ANTICANCER RESEARCH | 2006年 / 26卷 / 6C期
关键词：
GIST; imatinib mesylate; gastrointestinal; stromal tumors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Imatinib mesylate has undoubted efficacy in the treatment of advanced gastrointestinal stromal tumors (GISTs), but complete responses have only been reported rarely. Case report: A 47-year-old man with liver metastasis from GIST achieved a complete response after 7 months of treatment with imatinib and a 47-year old woman with local relapse of GIST on the stomach after gastrectomy, showed complete remission, 9 months after treatment with imatinib. Conclusion: Although the response rate is high in patients with advanced GIST treated with imatinib mesylate, complete responses remain rare. Several issues concerning its optimal administration need to be clarified, in order to improve its efficacy.
引用
收藏
页码：4869 / 4872
页数：4
相关论文
共 50 条
  • [41] Kinase Mutations and Imatinib Mesylate Response for 64 Taiwanese with Advanced GIST: Preliminary Experience from Chang Gung Memorial Hospital
    Chun-Nan Yeh
    Tsung-Wen Chen
    Hsiang-Lin Lee
    Yu-Yin Liu
    Tzu-Chieh Chao
    Tsann-Long Hwang
    Yi-Yin Jan
    Miin-Fu Chen
    Annals of Surgical Oncology, 2007, 14 : 1123 - 1128
  • [42] Clinical Significance of Pathological Complete Response in Patients with Metastatic Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment - Lessons Learned
    Cheng, Chi-Tung
    Tsai, Chun-Yi
    Yeh, Chun-Nan
    Chiang, Kun-Chun
    Chen, Yen-Yang
    Wang, Shang-Yu
    Chen, Tsung-Wen
    Tseng, Jeng-Hwei
    Jung, Shih-Ming
    Chen, Tse-Ching
    Yeh, Ta-Sen
    ANTICANCER RESEARCH, 2014, 34 (11) : 6617 - 6625
  • [43] Morphologic features of response to Gleevec (Imatinib) treatment of GIST
    Colecchia, M
    Diment, J
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2003, 11 (02) : 119 - 119
  • [44] Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST
    Gasparotto, Daniela
    Miolo, Gianmaria
    Torrisi, Elena
    Canzonieri, Vincenzo
    Bertola, Giulio
    Libra, Massimo
    Marzotto, Alessandra
    Maestro, Roberta
    Buonadonna, Angela
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (05) : 639 - 640
  • [45] Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate
    Perseghin, P
    Gambacorti-Passerini, C
    Tornaghi, L
    Dassi, M
    Pioltelli, P
    Parma, M
    Colnaghi, T
    Giudici, G
    Elli, E
    Fumagalli, M
    Ponchio, L
    Biondi, A
    Pogliani, EM
    TRANSFUSION, 2005, 45 (07) : 1214 - 1220
  • [46] Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate
    Ault, P
    Cortes, J
    Koller, C
    Kaled, ES
    Kantarjian, H
    LEUKEMIA RESEARCH, 2002, 26 (09) : 881 - 884
  • [47] Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST
    Daniela Gasparotto
    Gianmaria Miolo
    Elena Torrisi
    Vincenzo Canzonieri
    Giulio Bertola
    Massimo Libra
    Alessandra Marzotto
    Roberta Maestro
    Angela Buonadonna
    International Journal of Colorectal Disease, 2014, 29 : 639 - 640
  • [48] Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumor
    Quezada, Nicolas
    Acevedo, Francisco
    Marambio, Andres
    Leon, Felipe
    Galindo, Hector
    Roa, Juan Carlos
    Jarufe, Nicolas
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2014, 5 (10): : 681 - 685
  • [49] PET scanning evaluation of response to Imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients
    Gelibter, A
    Milella, M
    Ceribelli, A
    Zeuli, M
    Ferraresi, V
    Vecchione, A
    Cognetti, F
    ANTICANCER RESEARCH, 2004, 24 (5B) : 3147 - 3151
  • [50] Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST
    Gronchi, Alessandro
    Fiore, Marco
    Miselli, Francesca
    Lagonigro, Maria Stefania
    Coco, Paola
    Messina, Antonella
    Pilotti, Silvana
    Casali, Paolo Giovanni
    ANNALS OF SURGERY, 2007, 245 (03) : 341 - 346
12345